geslora 5 mg por tbl flm 100x5mg i - Keresési eredmények

Egyesült Államok - angol - NLM (National Library of Medicine)

suprelorin f- deslorelin acetate implant

virbac ah, inc. - deslorelin acetate (unii: 679007nr5c) (deslorelin - unii:tkg3i66tve) - deslorelin acetate 4.7 mg - suprelorin® f (4.7 mg) implant is indicated for the management of adrenal gland cortical disease in the male and female domestic ferret. do not use this product in ferrets with known hypersensitivity to deslorelin acetate or other synthetic hormones.

Egyesült Államok - angol - NLM (National Library of Medicine)

clarinex- desloratidine tablet, film coated

physicians total care, inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - clarinex is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets 5 mg are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients, or to loratadine. there is no information to indicate that abuse or dependency occurs with clarinex tablets.

Írország - angol - HPRA (Health Products Regulatory Authority)

desloratadine 0.5 mg/ml oral solution

accord healthcare ireland ltd. - desloratidine - oral solution - 0.5 milligram(s)/millilitre - other antihistamines for systemic use; desloratadine

Egyesült Államok - angol - NLM (National Library of Medicine)

clarinex- desloratadine tablet, film coated

a-s medication solutions - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - clarinex® is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets, reditabs, and oral solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with clarinex in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the

Egyesült Államok - angol - NLM (National Library of Medicine)

clarinex- desloratadine tablet, film coated

organon llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - clarinex® is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets, reditabs, and oral solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with clarinex in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the